Publicaciones (143) Publicaciones de Iván Peñuelas Sánchez

2023

  1. A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer

    Frontiers in Immunology, Vol. 14

  2. Corrigendum to “Development of intranasal implantable devices for schizophrenia treatment” [Int. J. Pharm. 624 (2021) 122061] (International Journal of Pharmaceutics (2022) 624, (S0378517322006159), (10.1016/j.ijpharm.2022.122061))

    International Journal of Pharmaceutics

  3. Encapsulation of Lactobacillus plantarum in casein-chitosan microparticles facilitates the arrival to the colon and develops an immunomodulatory effect

    Food Hydrocolloids, Vol. 136

  4. Highlight selection of radiochemistry and radiopharmacy developments by editorial board

    EJNMMI Radiopharmacy and Chemistry, Vol. 8, Núm. 1

  5. Infection-specific PET imaging with 18F-fluorodeoxysorbitol and 2-[18F]F-ρ-aminobenzoic acid: An extended diagnostic tool for bacterial and fungal diseases

    Frontiers in Microbiology, Vol. 14

  6. Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates

    Brain : a journal of neurology, Vol. 146, Núm. 12, pp. 5000-5014

  7. Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  8. Radiolabeled Risperidone microSPECT/CT Imaging for Intranasal Implant Studies Development

    Pharmaceutics, Vol. 15, Núm. 3

  9. TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory

    Cancer Cell, Vol. 41, Núm. 11, pp. 1911-1926.e8

  10. Zein-based nanospheres and nanocapsules for the encapsulation and oral delivery of quercetin

    International Journal of Pharmaceutics, Vol. 643

2022

  1. A new animal model of atrophy–hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits

    Scientific Reports, Vol. 12, Núm. 1

  2. Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism

    Neurobiology of Disease, Vol. 167

  3. Correction to: EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3 (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 49, 2, (632-651), 10.1007/s00259-021-05603-w)

    European Journal of Nuclear Medicine and Molecular Imaging

  4. Development of intranasal implantable devices for schizophrenia treatment

    International Journal of Pharmaceutics, Vol. 624

  5. EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 2, pp. 632-651

  6. High value of 64Cu as a tool to evaluate the restoration of physiological copper excretion after gene therapy in Wilson's disease

    Molecular Therapy - Methods and Clinical Development, Vol. 26, pp. 98-106

  7. Performance evaluation of a preclinical SPECT/CT system for multi-animal and multi-isotope quantitative experiments

    Scientific Reports, Vol. 12, Núm. 1

  8. Preclinical safety of negatively charged microspheres (NCMs): Optimization of radiolabeling for in vivo and ex vivo biodistribution studies after topical administration on full-thickness wounds in a rat model

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 177, pp. 61-67

2021

  1. Engineering a genome-reduced bacterium to eliminate Staphylococcus aureus biofilms in vivo

    Molecular Systems Biology, Vol. 17, Núm. 10

  2. Glucocerebrosidase gene therapy induces alpha-synuclein clearance and neuroprotection of midbrain dopaminergic neurons in mice and macaques

    International Journal of Molecular Sciences, Vol. 22, Núm. 9